Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation?
- PMID: 7683540
Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation?
Abstract
The insulin-like growth factor binding proteins (IGFBP) modulate the regulatory actions of insulin-like growth factors (IGF) on fetal growth and development. We have determined the sites of IGFBP-4, -5 and -6 synthesis in 14-18 weeks gestation human fetal tissues using northern blot analysis and in situ hybridization to localize their mRNAs. IGFBP-4, -5 and -6 mRNAs were present in most fetal tissues at this gestational age. IGFBP-4 mRNA (2.3 kb) was widely expressed, most abundantly in kidney, stomach, intestine and lung and least in the liver. IGFBP-5 mRNA (6 kb) was in highest abundance in muscle, skin, stomach and intestine. IGFBP-6 mRNA (1.4 kb) was expressed with greatest abundance in the heart, muscle and skin and least in the liver. In situ hybridization confirmed the widespread occurrence of these mRNAs. The distribution of all three IGFBP mRNAs was similar in each tissue with variations in relative abundance between different regions. In general, IGFBP-4, -5 and -6 mRNAs were prevalent in regions of active cellular division and differentiation, suggesting that the binding proteins they encode specify the sites of IGF activity in the developing fetus. The widespread occurrence of their mRNAs suggests that, like IGFs, they are synthesized in multiple tissues in the fetus and have an autocrine or paracrine mode of action.
Similar articles
-
Expression of insulin-like growth factor binding protein-4 and -5 mRNAs in adult rat forebrain.J Comp Neurol. 1994 Jan 1;339(1):91-105. doi: 10.1002/cne.903390109. J Comp Neurol. 1994. PMID: 7508953
-
The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.J Clin Endocrinol Metab. 1996 Jul;81(7):2680-93. doi: 10.1210/jcem.81.7.8675597. J Clin Endocrinol Metab. 1996. PMID: 8675597
-
The expression of insulin-like growth factor and insulin-like growth factor binding protein mRNAs in mouse placenta.Placenta. 2006 Feb-Mar;27(2-3):278-90. doi: 10.1016/j.placenta.2005.01.014. Placenta. 2006. PMID: 16338473
-
IGF binding proteins and their functions.Mol Reprod Dev. 1993 Aug;35(4):368-74; discussion 374-5. doi: 10.1002/mrd.1080350409. Mol Reprod Dev. 1993. PMID: 7691098 Review.
-
Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth.Growth Regul. 1994 Sep;4(3):91-100. Growth Regul. 1994. PMID: 7532055 Review.
Cited by
-
Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Crit Rev Oncog. 2015;20(5-6):373-90. doi: 10.1615/CritRevOncog.v20.i5-6.100. Crit Rev Oncog. 2015. PMID: 27279236 Free PMC article. Review.
-
Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.J Neurooncol. 2002 Mar;57(1):19-26. doi: 10.1023/a:1015765613544. J Neurooncol. 2002. PMID: 12125963
-
Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.Eur J Pediatr. 1996 Feb;155(2):81-6. doi: 10.1007/BF02075755. Eur J Pediatr. 1996. PMID: 8775218
MeSH terms
Substances
LinkOut - more resources
Miscellaneous